Modular Medical Announces Independent Study Supports Favorable Payor Receptivity To Pivot's Differentiated Design, Simplified User Experience

8-K filing — Modular Medical, Inc. (MODD)

Filed: 2026-09-29 AccNo: 0001213900-26-104656 Size: 186 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Modular Medical Secures National PBM Contract For Pivot Insulin Pump

Modular Medical secured a national PBM contract to expand access to its Pivot tubeless insulin patch pump for patients managing diabetes.

Modular Medical Receives Contract From Undisclosed U.S. Pharmacy Benefit Manager To Provide Its Insulin Delivery System

Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the commercial launch of its next-generation Pivot™ tubeless patch pump,

Modular Medical Says FDA Cleared Software Enhancements To Pivot Tubeless Patch Pump, Including Bolus Dosing Customization And User-Interface Upgrades, Ahead Of Planned Q4 Launch